Key Insights

Highlights

Success Rate

84% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

4.3%

3 terminated out of 70 trials

Success Rate

84.2%

-2.3% vs benchmark

Late-Stage Pipeline

7%

5 trials in Phase 3/4

Results Transparency

13%

2 of 16 completed with results

Key Signals

2 with results84% success

Data Visualizations

Phase Distribution

57Total
Not Applicable (41)
Early P 1 (1)
P 1 (1)
P 2 (9)
P 3 (3)
P 4 (2)

Trial Status

Unknown22
Recruiting19
Completed16
Withdrawn5
Not Yet Recruiting4
Terminated3

Trial Success Rate

84.2%

Benchmark: 86.5%

Based on 16 completed trials

Clinical Trials (70)

Showing 20 of 20 trials
NCT06401772Not ApplicableRecruitingPrimary

The Effectiveness and Safety of Body Posture in Preventing Postoperative Recurrence for Chronic Subdural Hematoma

NCT04750200Not ApplicableActive Not RecruitingPrimary

Management of CSDH With or Without EMMA- a Randomized Control Trial

NCT04816591Not ApplicableCompletedPrimary

Middle Meningeal Artery Embolization for the Treatment of Subdural Hematomas With TRUFILL® n-BCA

NCT06347796Not ApplicableRecruitingPrimary

Chronic Subdural Hematoma Treatment With Embolization Versus Surgery Study

NCT04966546Early Phase 1WithdrawnPrimary

Targeting Spreading Depolarization After Chronic Subdural Hematoma Surgery (TASD)

NCT07421453RecruitingPrimary

Implementation of an Enhanced Recovery Pathway for Burr-hole Drainage in Patients With a Chronic Subdural Hematoma

NCT07144423Not ApplicableRecruitingPrimary

Neuroendoscopy-assisted Drainage Versus Burr Hole Drainage for Chronic Subdural Hematoma

NCT05374681Not ApplicableRecruitingPrimary

Efficacy of a Minimally Invasive Therapy Adjuvant to the Standards of Care by Cyanoacrylate Embolization

NCT07368101Not ApplicableCompletedPrimary

Outcome of Chronic Subdural Hematoma Management With Double Burr Hole Craniotomy Versus Single Burr Hole Craniotomy and Subdural Drain Evacuation

NCT07324551RecruitingPrimary

Microfabricated Microcatheter Advantages in Middle Meningeal Artery Embolization: an Early Experience at a Single Center

NCT06181994RecruitingPrimary

Middle Meningeal Artery Embolization (MMAE) Outcomes for Chronic Subdural Hematoma (cSDH)

NCT07245264Phase 2RecruitingPrimary

Adjuvant Tranexamic Acid (TXA) Versus Surgery Alone for Adult Patients With Chronic Subdural Hematoma (CSDH)

NCT06621407Not ApplicableRecruitingPrimary

A National Study Examining the Most Effective Drainage Method After Burr Hole Evacuation of Chronic Subdural Hematoma

NCT07240454Not ApplicableRecruitingPrimary

Aspirin Continuation or Discontinuation in Conservative Treatment for Chronic Subdural Hematoma

NCT07214623Not Yet RecruitingPrimary

Prospective Multi-center Single Arm Study for Subjects With Chronic Subdural Hematoma Treated With i-ED COILs, Either Alone or in Combination With Burr-holes or Mini-craniotomy

NCT06696079Not ApplicableRecruitingPrimary

Restarting Early Versus Later Anticoagulation for Chronic Subdural Hematoma With Atrial Fibrillation

NCT04065113WithdrawnPrimary

Middle Meningeal Artery Embolization for Chronic Subdural Hematoma

NCT06127615Not ApplicableWithdrawnPrimary

The Efficacy of the Longeviti ClearFit Implant in Craniectomies for Post-Operative Monitoring in Chronic Subdural Hematomas

NCT06510582Phase 1RecruitingPrimary

Chronic Subdural Hematoma Treatment With Intra-Arterial Bevacizumab Injection

NCT04850612CompletedPrimary

Defining Core Outcomes and Data Elements (CODE) in Chronic Subdural Haematoma

Scroll to load more

Research Network

Activity Timeline